Announcements Trials
Browse Landscape

Phase

Phase NA 7Phase 2 5Phase 3 4Phase 1 2Phase EARLY_PHASE1 1Phase 1/2 1

Status

Completed 3Terminated 1

Sponsor Class

NETWORK 5OTHER 4NIH 2OTHER_GOV 1

Study Type

Interventional 4

Sponsor

Cancer Type

Genitourinary 2Other neoplasm 1Gastrointestinal 1

Conditions

Urinary Bladder Neoplasms 1Rectal Neoplasms 1Prostatic Neoplasms 1Precancerous Conditions 1Colorectal Neoplasms 1Colonic Neoplasms 1Arsenic Poisoning 1Adenomatous Polyps 1

Interventions

Cisplatin 294Radiotherapy 230Fluorouracil 201Cyclophosphamide 191Capecitabine 182Docetaxel 166Gemcitabine 165Oxaliplatin 162Carboplatin 160Paclitaxel 152Leucovorin 122Drug Therapy 118Dexamethasone 118Doxorubicin 112Etoposide 99Bevacizumab 91Cytarabine 87Vincristine 83Irinotecan 81Rituximab 77Epirubicin 71Prednisone 65Radiosurgery 63Methotrexate 62Surgical Procedures, Operative 61Radiation 60Radiotherapy, Intensity-Modulated 56Neoadjuvant Therapy 53Lenalidomide 52Letrozole 50

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

4 trials
RecentStart dateEnrollment
Phase 3 × OTHER × Selenium × Clear all
NCT00078897 2019-09-24

Selenium for Prevention of Adenomatous Colorectal Polyps

University of Arizona

Phase 3 Terminated
1,621 enrolled 12 charts
GastrointestinalOther neoplasm

Colonic Neoplasms, Precancerous Conditions, Rectal Neoplasms, Colorectal Neoplasms, Adenomatous Polyps

NCT00729287 2016-05-12

SELEBLAT

KU Leuven

Phase 3 Completed
276 enrolled
Genitourinary

Urinary Bladder Neoplasms

NCT00978718 2012-08-15

Selenium in Preventing Prostate Cancer

University of Arizona

Phase 3 Completed
700 enrolled
Genitourinary

Prostatic Neoplasms

NCT01442727 2011-10-07

SETAC

Texas Tech University

Phase 3 Completed
819 enrolled

Arsenic Poisoning

Data powered by HemOnc (CC BY 4.0) Colophon âš¡